Company News

Share this article:

Gilead Sciences Inc. has agreed to pay $1.4 billion, or $20 a share, for CV Therapeutics, a manufacturer of chest pain and heart drugs. The bid tops Astellas' $16-a-share bid for CV Therapeutics, announced last January.

 

GSW Worldwide's Pink Tank, an agency specializing in health marketing to women, has launched a new web site: www.knowher.com. The site provides information about strategic consulting services for clients who want to reach women consumers.

Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.